MZ 5156
Alternative Names: MZ-5-156Latest Information Update: 18 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antihormones
- Mechanism of Action Insulin-like growth factor II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pancreatic cancer
Most Recent Events
- 18 Apr 2002 No development reported - Preclinical for Pancreatic cancer in USA (unspecified route)
- 02 Mar 2000 New profile
- 02 Mar 2000 Preclinical development for Pancreatic cancer in USA (Unknown route)